ICL Group declares $0.0488 dividend declines by 16% to $0.0488 (NYSE:ICL)

ICL Group (ICL) announced a quarterly dividend of $0.0488 per share, a 16% decrease from the previous dividend of $0.0581. The forward yield is 4.18%, with the dividend payable on December 16 to shareholders of record on December 2.

Original reporting
Published Nov 11, 2026, 6:53 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 6:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$ICL
Bearish
high confidence
Mentioned
$ICL
Relevance
5/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$ICLBearishMed
01

Why it matters

The dividend reduction may trigger short‑term price decline but could improve long‑term balance sheet flexibility.

02

Market read

Dividend cuts are closely watched by income‑focused investors; this announcement provides a fresh data point for trading decisions.

03

What to watch

Potential hidden benefits from retained earnings for R&D or debt reduction are not reflected in the dividend headline.

Relevance 5/10Novelty 7/10Timing: today

Background

ICL Group is a major global fertilizer and specialty chemicals producer listed on NYSE under ICL.

Company-level read

Ticker impact

$ICLBearishHigh confidence
Context

ICL announced a quarterly dividend of $0.0488 per share, a 16% reduction from the prior $0.0581.

Expected impact

likely downward pressure as investors price in reduced yield

Evidence & confidence

Dividend reductions are typically viewed as a negative signal for earnings stability.

Market effects

Lower dividend may affect other fertilizer and chemicals peers as investors reassess sector cash flow outlook.

Minimal impact beyond Israel Chemicals and its immediate market.

Limited; primarily relevant to investors holding ICL or tracking dividend‑focused funds.

Counterpoint

The cut could be a temporary adjustment; the lower payout may free cash for strategic acquisitions or cap‑ex, offering upside potential.

Key entities

  • ICL Group

    Global fertilizer and chemicals producer.

Related articles

$ICLMedAI 8/10

ICL Group Ltd (ICL) Q3 2026 Earnings Call Highlights: Industrial Strength and Cost Cuts

ICL Group Ltd reported Q3 2026 earnings, with CEO Elad Aronson and CFO Assaf discussing market outlook, segment performance, and cost management. Key points include stable potash demand, rising phosphate fertilizer demand, and falling sulfur prices. Industrial products sales rose 18% YoY to $347M, with EBITDA up nearly 50%. Potash EBITDA declined 7% YoY due to higher costs. The company expects 2026 EBITDA to be within the $1.5B-$1.7B guidance range, with relief from sulfur costs in 2027.

$ICLMed

ICL Group Ltd Q3 2026 Earnings Call Summary

ICL Group Ltd reported Q3 2026 earnings, highlighting growth from strategic price increases and high-margin products. Key segments showed mixed results: Industrial Products benefited from bromine price increases, Phosphate Solutions saw resilience in specialty products, and Potash margins faced pressure. The company expects 2026 EBITDA of $1.5B-$1.7B and $150M EBITDA improvement in 2027 from cost-cutting.

$ICLMedAI 8/10

ICL Group Q3 Earnings Call Highlights

ICL Group reported Q3 average potash price at $370/ton, up 5% YoY. Phosphate Solutions sales were $589M, EBITDA $118M. Growing Solutions sales were $538M, EBITDA $44M. Sulfur costs rose 220% YoY, impacting Q4. ICL expects $150M EBITDA improvement by 2027. Company to reorganize segments in 2027. Maintained 2026 potash sales forecast of 4.5-4.7M metric tons. Paid $63M dividend in Q3.

$ICLHighAI 8/10

ICL Group (ICL) Q3 2026 Earnings Call Transcript

ICL Group reported Q3 2026 adjusted net income of $126M, up 2%, with EPS at $0.10. Operating cash flow was $256M, and free cash flow was $66M. Industrial Products sales rose 18% YoY, driven by higher bromine prices. Potash sales increased 4% YoY, but EBITDA fell 7% due to cost pressures. Phosphate Solutions sales were $589M with a 20% EBITDA margin, despite higher raw material costs. Growing Solutions sales were $538M with EBITDA of $44M, facing market challenges in Brazil.